Evidence map›Paper›PMID 40352015›Full record

ArticleCureus2025

Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.

Simon G Ammanuel, Matthew Stenerson, Thomas Staniszewski, Manasa Kalluri, Benjamin Lee, Elsa Nico, Azam S Ahmed

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon G AmmanuelDepartment of Neurological Surgery, University of Wisconsin Hospitals and Clinics, Madison, USA.
Matthew StenersonDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Thomas StaniszewskiDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Manasa KalluriDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Benjamin LeeDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Elsa NicoDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Azam S AhmedDepartment of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Meningiomas commonly recur following gross total resection (GTR), and the risk of recurrence is difficult to predict using current classification schemes such as the World Health Organization (WHO) tumor grade. This study aimed to create a predictive model of recurrence risk following GTR of WHO grade 1 meningiomas based on histopathological and epidemiological factors.  Methods A retrospective chart review was completed for all patients at our institution who underwent their first surgery for a WHO grade 1 meningioma between 2017 and 2022. Those with genetic predispositions, such as neurofibromatosis type 2, were excluded. Baseline characteristics, including histopathology findings, were obtained, and we used a Risk-calibrated Superspase Linear Integer Model (Risk-SLIM) with a five-fold cross-validation (CV) to create a predictive model of recurrence over an average follow-up of three years.  Results Univariate analysis of our selected variables revealed a significant predictive association between WHO grade 1 meningioma recurrence and subtotal resection but not with any other variable. However, the meningioma recurrence score (MRS) generated by our machine learning algorithm revealed multiple predictive factors of recurrence, including age, female gender, and various histopathologic features, including the Ki-67/MIB-1 index. Conclusions Machine learning algorithms like the one we present here may help identify patients at high risk of recurrence of their WHO grade 1 meningioma, and they are more likely to benefit from closer postoperative surveillance or adjuvant treatment, even when GTR is achieved.

Indexed as

artificial intelligencegrade 1 meningiomamachine learningmeningiomaneurosurgery

Identifiers

PMID40352015
PMCPMC12065630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.